Dennis Podlesak

Managing Partner at Canaan Partners’ Axcelius

Total Funding: $180M

Total Funding: $7M

Total Funding: $7M

Oct. 2024

The webpage confirms Dennis Podlesak is the CEO and Managing Partner of Canaan Partners’ Axcelius since September 2019

Aug. 2024

This ContactOut page confirms that Dennis Podlesak is the CEO & Managing Partner at Canaan Partners’ Axcelius

May 2024

Summary: The webpage for Transposon Therapeutics, Inc

Apr. 2024

Dennis Podlesak's LinkedIn profile confirms he is the CEO & Managing Partner at Canaan Partners’ Axcelius, a position he's held since September 2019